Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 14
2004 5
2005 8
2006 5
2007 3
2008 4
2009 1
2011 1
2012 1
2013 3
2014 1
2015 2
2016 2
2017 1
2020 2
2021 6
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean david h miller[Author] (215 results)?
The mechanisms of action of PPARs.
Berger J, Moller DE. Berger J, et al. Among authors: moller de. Annu Rev Med. 2002;53:409-35. doi: 10.1146/annurev.med.53.082901.104018. Annu Rev Med. 2002. PMID: 11818483 Review.
Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.
Hallakou-Bozec S, Vial G, Kergoat M, Fouqueray P, Bolze S, Borel AL, Fontaine E, Moller DE. Hallakou-Bozec S, et al. Among authors: moller de. Diabetes Obes Metab. 2021 Mar;23(3):664-673. doi: 10.1111/dom.14277. Epub 2020 Dec 29. Diabetes Obes Metab. 2021. PMID: 33269554 Free PMC article. Review.
Reflections on the field of metabolism.
Moller DE, Cuervo AM, Gordon J, Froguel P, Mangelsdorf DJ. Moller DE, et al. Cell Metab. 2015 Apr 7;21(4):505-6. doi: 10.1016/j.cmet.2015.03.009. Cell Metab. 2015. PMID: 26042242 Free article. No abstract available.
Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin.
Theurey P, Vial G, Fontaine E, Monternier PA, Fouqueray P, Bolze S, Moller DE, Hallakou-Bozec S. Theurey P, et al. Among authors: moller de. Physiol Rep. 2022 Mar;10(5):e15151. doi: 10.14814/phy2.15151. Physiol Rep. 2022. PMID: 35274817 Free PMC article.
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1).
Harrison SA, Thang C, Bolze S, Dewitt S, Hallakou-Bozec S, Dubourg J, Bedossa P, Cusi K, Ratziu V, Grouin JM, Moller DE, Fouqueray P. Harrison SA, et al. Among authors: moller de. J Hepatol. 2023 May;78(5):914-925. doi: 10.1016/j.jhep.2023.02.004. Epub 2023 Feb 18. J Hepatol. 2023. PMID: 36804402 Clinical Trial.
65 results